Hanni Menn-Josephy, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Menn-Josephy is a board-certified nephrologist with a special interest in Autoimmune Kidney Diseases and Lupus Nephritis. She serves as the Nephrology Director of the Lupus Multidisciplinary Program at Boston Medical Center, which operates as a regional and national referral center for patients who suffer from lupus and lupus nephritis.
Together with her colleagues, Dr. Menn-Josephy developed a unique care model that enables lupus and lupus nephritis patients to receive comprehensive care from rheumatology, nephrology, and dermatology disciplines, improving their health and reducing health-related disparities. Dr. Menn-Josephy conducts groundbreaking clinical trials, including pioneering CAR-T therapy for lupus nephritis, and is committed to providing novel therapies to lupus patients. Over the past years. she has been involved is establishing educational programs in the field of lupus nephritis on institutional, regional, and national levels.

As part of her interest in translational research in the field of lupus nephritis, Dr. Menn-Josephy, along with her colleagues, established an autoimmunity clinical registry and patient biobank with the goal of studying lupus pathogenesis to identify new therapeutic targets.

Dr. Menn-Josephy serves as the Associate Program Director for the Nephrology Fellowship Program, where she established a coaching initiative for fellows to enhance their sense of belonging and well-being within the section. This program provides personalized mentorship and professional development opportunities, creating a supportive environment that helps fellows thrive during their specialized training.

Publications

  • Published 8/24/2024

    Siskind SM, Yadav S, Solomon M, Knapp PE, Menn-Josephy H, Francis J, Rennke HG, Ayalon R, Modzelewski KL. Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer. AACE Clin Case Rep. 2024; 10(6):244-248. PMID: 39734505.

    Read at: PubMed

  • Published 12/18/2023

    Menn-Josephy H, Hodge LS, Birardi V, Leher H. Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria. Clin J Am Soc Nephrol. 2024 Mar 01; 19(3):309-318. PMID: 38110196.

    Read at: PubMed

  • Published 2/22/2023

    Schmidt IM, Shohet M, Serrano M, Yadati P, Menn-Josephy H, Ilori T, Eneanya ND, Cleveland Manchanda EC, Waikar SS. Patients' Perspectives on Race and the Use of Race-Based Algorithms in Clinical Decision-Making: a Qualitative Study. J Gen Intern Med. 2023 Jul; 38(9):2045-2051. PMID: 36811702.

    Read at: PubMed

  • Published 6/23/2022

    Nader R, Zhen A, Angel-Korman A, Pavlovich SS, Pogrebinsky A, Doros G, Menn-Josephy H, Stern L, Sanchorawala V, Havasi A. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2022 Jun 23; 37(7):1281-1288. PMID: 34043009.

    Read at: PubMed

  • Published 6/15/2021

    Li H, Tsokos MG, Bhargava R, Adamopoulos IE, Menn-Josephy H, Stillman IE, Rosenstiel P, Jordan J, Tsokos GC. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J Clin Invest. 2021 06 15; 131(12). PMID: 33956666.

    Read at: PubMed

Other Positions

  • Member, Amyloidosis Center
    Boston University

Education

  • Technion - Israel Institute of Technology, MD
  • Ben-Gurion University of the Negev, BSc